Pepijn Vemer

1.1k total citations
31 papers, 809 citations indexed

About

Pepijn Vemer is a scholar working on Economics and Econometrics, General Health Professions and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Pepijn Vemer has authored 31 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 15 papers in General Health Professions and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Pepijn Vemer's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Healthcare Policy and Management (8 papers) and Global Health Care Issues (4 papers). Pepijn Vemer is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Healthcare Policy and Management (8 papers) and Global Health Care Issues (4 papers). Pepijn Vemer collaborates with scholars based in Netherlands, United States and Austria. Pepijn Vemer's co-authors include Maureen Rutten‐van Mölken, Talitha Feenstra, Isaac Corro Ramos, Maiwenn Al, G.A.K. van Voorn, Lucas Goossens, Maarten J. Postma, Jerome R. Lo-Ten-Foe, Bhanu Sinha and Alex W. Friedrich and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and Addiction.

In The Last Decade

Pepijn Vemer

31 papers receiving 788 citations

Peers

Pepijn Vemer

GHP

EPIDE

EDM

CCM

Olivier Bugnon Switzerland

Debi Bhattacharya United Kingdom

Teresa M. Salgado United States

Mikael Hoffmann Sweden

Junling Wang United States

Amol A. Verma Canada

Stefan Neuner‐Jehle Switzerland

Anna Kemp Australia

Marcia Vervloet Netherlands

Abiy Agiro United States

Olivier Bugnon Switzerland

Pepijn Vemer

196 ×0.8

271 ×1.3

GHP

151 ×1.4

EPIDE

66 ×0.7

EDM

119 ×1.4

CCM

Citations per year, relative to Pepijn Vemer Pepijn Vemer (= 1×) peers Olivier Bugnon

Countries citing papers authored by Pepijn Vemer

Since Specialization

Citations

This map shows the geographic impact of Pepijn Vemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pepijn Vemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pepijn Vemer more than expected).

Fields of papers citing papers by Pepijn Vemer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pepijn Vemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pepijn Vemer. The network helps show where Pepijn Vemer may publish in the future.

Co-authorship network of co-authors of Pepijn Vemer

This figure shows the co-authorship network connecting the top 25 collaborators of Pepijn Vemer. A scholar is included among the top collaborators of Pepijn Vemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pepijn Vemer. Pepijn Vemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goossens, Lucas, Pepijn Vemer, & Maureen Rutten‐van Mölken. (2020). The risk of overestimating cost savings from hospital-at-home schemes: A literature review. International Journal of Nursing Studies. 109. 103652–103652. 12 indexed citations

Gout-Zwart, Judith J., et al.. (2019). Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review. PLoS ONE. 14(9). e0221856–e0221856. 9 indexed citations

Asselt, Antoinette D. I. van, Bram Ramaekers, Isaac Corro Ramos, et al.. (2017). Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research. PharmacoEconomics. 36(1). 105–113. 5 indexed citations

Ramos, Isaac Corro, George A.K. van Voorn, Pepijn Vemer, Talitha Feenstra, & Maiwenn Al. (2017). A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data. Value in Health. 20(8). 1041–1047. 6 indexed citations

Blommestein, Hedwig M., Saskia de Groot, Mieke J. Aarts, et al.. (2016). Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands. Leukemia Research. 50. 37–45. 12 indexed citations

Asselt, Antoinette D. I. van, Isaac Corro Ramos, Ivonne Lesman‐Leegte, et al.. (2016). Estimating Study Costs For Use In Voi, A Study Of Dutch Publicly Funded Drug Related Research. Value in Health. 19(7). A479–A480. 1 indexed citations

Dik, Jan-Willem H., Ariane Dinkelacker, Pepijn Vemer, et al.. (2016). Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital. PLoS ONE. 11(2). e0149226–e0149226. 24 indexed citations

Postma, Maarten J., et al.. (2016). An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands. Value in Health. 20(3). 388–396. 28 indexed citations

Voorn, George A.K. van, Pepijn Vemer, Dominique Hamerlijnck, et al.. (2015). The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling. Applied Health Economics and Health Policy. 14(2). 129–133. 32 indexed citations

10.

Boven, Job F. M. van & Pepijn Vemer. (2015). Higher Adherence During Reimbursement of Pharmacological Smoking Cessation Treatments. Nicotine & Tobacco Research. 18(1). ntv064–ntv064. 14 indexed citations

11.

Dik, Jan-Willem H., Pepijn Vemer, Alex W. Friedrich, et al.. (2015). Financial evaluations of antibiotic stewardship programs—a systematic review. Frontiers in Microbiology. 6. 317–317. 55 indexed citations

12.

Vemer, Pepijn, et al.. (2014). Advishe: a New Tool to Report Validation of Health-Economic Decision Models. Value in Health. 17(7). A556–A557. 4 indexed citations

13.

Bouwmans, Clazien, Pepijn Vemer, Annemieke van Straten, Siok Swan Tan, & Leona Hakkaart‐van Roijen. (2014). Health-Related Quality of Life and Productivity Losses in Patients With Depression and Anxiety Disorders. Journal of Occupational and Environmental Medicine. 56(4). 420–424. 28 indexed citations

14.

Vemer, Pepijn, Maiwenn Al, Mark Oppe, & Maureen Rutten‐van Mölken. (2013). A Choice That Matters?. PharmacoEconomics. 31(8). 719–730. 3 indexed citations

15.

Bouwmans, Clazien, et al.. (2013). Let’s get back to work: survival analysis on the return-to-work after depression. Neuropsychiatric Disease and Treatment. 9. 1637–1637. 24 indexed citations

16.

Vemer, Pepijn & Maureen Rutten‐van Mölken. (2013). The Road Not Taken: Transferability Issues in Multinational Trials. PharmacoEconomics. 31(10). 863–876. 6 indexed citations

17.

Goossens, Lucas, Pepijn Vemer, & Maureen Rutten‐van Mölken. (2012). A systematic review of hospital-at-home care: cost savings are overestimated.. International Journal of Nursing Studies. 109. 108 indexed citations

18.

Goossens, Liesbet, Pepijn Vemer, & Maureen Rutten‐van Mölken. (2012). PHP70 A Systematic Review of Hospital-at-Home Care: Cost Savings are Overestimated. Value in Health. 15(7). A301–A301. 3 indexed citations

19.

Vemer, Pepijn, Maureen Rutten‐van Mölken, James B. Kaper, et al.. (2010). If you try to stop smoking, should we pay for it? The cost–utility of reimbursing smoking cessation support in the Netherlands. Addiction. 105(6). 1088–1097. 13 indexed citations

20.

Vemer, Pepijn & Maureen Rutten‐van Mölken. (2009). Crossing Borders: Factors Affecting Differences in Cost-Effectiveness of Smoking Cessation Interventions between European Countries. Value in Health. 13(2). 230–241. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact